by Matt Foor | Apr 5, 2012
Pearl Pathways is excited to announce the release of its case studies. Be sure to check out our case study section to see how Pearl offers real solutions to companies ranging from small startups to large multi-nationals. Pearl is proud to share its work and the...
by Matt Foor | Mar 26, 2012
FDA has released a draft guidance which lays out a framework for the agency’s response to post-marketing safety issues. These issues include serious adverse events, product quality issues and medication errors. FDA has also drafted a ranking system to help...
by Matt Foor | Mar 26, 2012
Save the date April 26, 2012 for the AAPS Indiana/Ohio Discussion Group (IODG) as they will talk about a range of topics including pharmaceutical technology, drug delivery systems, and regulatory affairs. The event will start at 5:30pm on Thursday, April 26, 2012 at...
by Matt Foor | Mar 26, 2012
Please join Pearl Pathways at the upcoming INpact meeting on April 20, 2012. Pearl Pathways COO, Gretchen Bowker, will serve as a panelist at the meeting. The topic of the meeting will be the FDA 510(k) process and how it will affect and change medical devices...
by Matt Foor | Mar 23, 2012
According to Frost & Sullivan’s Aiswariya Chidambaram, the European CMO sector is set to double in the next six years. Revenues are said to hit $20.75 billion. The reason for this growth stem from the increasing incidence of generics and companies who will...
